Bruck Kifle

Array ( [id] => 1587030 [patent_doc_number] => 06359129 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same' [patent_app_type] => B1 [patent_app_number] => 09/639023 [patent_app_country] => US [patent_app_date] => 2000-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11994 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/359/06359129.pdf [firstpage_image] =>[orig_patent_app_number] => 09639023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4339178 [patent_doc_number] => 06333412 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Process for the preparation of .epsilon.-caprolactam' [patent_app_type] => 1 [patent_app_number] => 9/635717 [patent_app_country] => US [patent_app_date] => 2000-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3515 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333412.pdf [firstpage_image] =>[orig_patent_app_number] => 635717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600996 [patent_doc_number] => 06476019 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof' [patent_app_type] => B1 [patent_app_number] => 09/633411 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31502 [patent_no_of_claims] => 117 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 566 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/476/06476019.pdf [firstpage_image] =>[orig_patent_app_number] => 09633411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477938 [patent_doc_number] => 06344450 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Lactam compounds and their use as inhibitors of serine proteases and method' [patent_app_type] => B1 [patent_app_number] => 09/633751 [patent_app_country] => US [patent_app_date] => 2000-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9952 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344450.pdf [firstpage_image] =>[orig_patent_app_number] => 09633751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355843 [patent_doc_number] => 06218385 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-17 [patent_title] => '1,2,4,5-Tetrahydro-benzo[D]azepin derivatives' [patent_app_type] => 1 [patent_app_number] => 9/630702 [patent_app_country] => US [patent_app_date] => 2000-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45776 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1395 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/218/06218385.pdf [firstpage_image] =>[orig_patent_app_number] => 630702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658358 [patent_doc_number] => 07105508 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Integrin receptors antagonists' [patent_app_type] => utility [patent_app_number] => 10/049266 [patent_app_country] => US [patent_app_date] => 2000-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41754 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105508.pdf [firstpage_image] =>[orig_patent_app_number] => 10049266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 708189 [patent_doc_number] => 07060822 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-06-13 [patent_title] => '2-pyrazolin-5-ones' [patent_app_type] => utility [patent_app_number] => 09/621468 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57037 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/060/07060822.pdf [firstpage_image] =>[orig_patent_app_number] => 09621468 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1407084 [patent_doc_number] => 06534649 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Silica gel incorporating polyazacycloalkane units comprising more than six nitrogen atoms, preparation process and use' [patent_app_type] => B1 [patent_app_number] => 09/624341 [patent_app_country] => US [patent_app_date] => 2000-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6380 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 175 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534649.pdf [firstpage_image] =>[orig_patent_app_number] => 09624341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1561558 [patent_doc_number] => 06362178 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => '2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/554162 [patent_app_country] => US [patent_app_date] => 2000-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30775 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 2510 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362178.pdf [firstpage_image] =>[orig_patent_app_number] => 09554162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1495443 [patent_doc_number] => 06403575 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => '3-Pyridyl enantiomers and their use as analgesics' [patent_app_type] => B1 [patent_app_number] => 09/619229 [patent_app_country] => US [patent_app_date] => 2000-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 62328 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403575.pdf [firstpage_image] =>[orig_patent_app_number] => 09619229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4260954 [patent_doc_number] => 06258804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-10 [patent_title] => 'Triazepinones, process for their preparation and their therapeutic application' [patent_app_type] => 1 [patent_app_number] => 9/600294 [patent_app_country] => US [patent_app_date] => 2000-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1643 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/258/06258804.pdf [firstpage_image] =>[orig_patent_app_number] => 600294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1433463 [patent_doc_number] => 06340753 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-22 [patent_title] => 'Optically active quarternary ammonium salt with axial chirality, method for producing thereof, and application thereof for asymmetric synthesis of -amino acid' [patent_app_type] => B1 [patent_app_number] => 09/616361 [patent_app_country] => US [patent_app_date] => 2000-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19345 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 388 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/340/06340753.pdf [firstpage_image] =>[orig_patent_app_number] => 09616361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1420350 [patent_doc_number] => 06506744 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Benzazepinone-derivatives' [patent_app_type] => B1 [patent_app_number] => 09/611700 [patent_app_country] => US [patent_app_date] => 2000-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17304 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506744.pdf [firstpage_image] =>[orig_patent_app_number] => 09611700 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 975656 [patent_doc_number] => 06933299 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-08-23 [patent_title] => 'Anilinoquinazolines as protein tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/030527 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43640 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/933/06933299.pdf [firstpage_image] =>[orig_patent_app_number] => 10030527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1363349 [patent_doc_number] => 06569854 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-27 [patent_title] => 'Streptogramin derivatives, their preparation and compositions containing them' [patent_app_type] => B1 [patent_app_number] => 09/609717 [patent_app_country] => US [patent_app_date] => 2000-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53284 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 405 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/569/06569854.pdf [firstpage_image] =>[orig_patent_app_number] => 09609717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1470211 [patent_doc_number] => 06407087 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-18 [patent_title] => 'UCF116 derivatives' [patent_app_type] => B1 [patent_app_number] => 09/605014 [patent_app_country] => US [patent_app_date] => 2000-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6527 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/407/06407087.pdf [firstpage_image] =>[orig_patent_app_number] => 09605014 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475167 [patent_doc_number] => 06387932 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Somatostatin agonists' [patent_app_type] => B1 [patent_app_number] => 09/595142 [patent_app_country] => US [patent_app_date] => 2000-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12229 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 920 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/387/06387932.pdf [firstpage_image] =>[orig_patent_app_number] => 09595142 [rel_patent_id] =>[rel_patent_doc_number] =>)